Diagnostic News and Research

RSS

Olympus announces first results of its AI-based pathology diagnostic tool for gastric cancer

The results of Olympus’ ongoing joint research program to create an AI-based pathology diagnostic tool with the potential to streamline pathologists’ workloads were announced at the Japan Society of Digital Pathology Study annual meeting.

From Evident Corporation - Life Sciences 17 Nov 2021

New imaging software can accurately diagnose jaundice in the blink of an eye

Imagine a system that can detect within one second whether a newborn baby has jaundice, a condition affecting 60 per cent of infants, and in severe cases leading to brain damage and hearing loss.

17 Nov 2021

Urinary SARS-CoV-2 RNA is a prognosticator of COVID-19

A new study published in the journal Diagnostics was based on the hypothesis that detecting urinary SARS-CoV-2 nucleic acid––which may result in renal and cardiovascular endothelial destruction to facilitate viral access to the kidney parenchyma—may be used as a specific biomarker to indicate the severity of COVID-19.

16 Nov 2021

New AI application reads eye movements

Eye movements read by a new AI application can reveal thoughts, memories, goals — and brain diseases.

16 Nov 2021

Diagnostic sensitivity, viral load and infectivity of SARS-CoV-2 in paired respiratory and oral samples

To understand the viral load in different sections of infected individuals, their respective shedding patterns, and the sensitivity of the SARS-CoV-2 assays, researchers published a study.

16 Nov 2021

Rapid thermal cycling approach for the detection of SARS-CoV-2

Researchers develop an ultrafast detection method for SARS-CoV-2 by direct RT-PCR without RNA extraction that is suitable for large-scale use.

15 Nov 2021

Smiths Detection: Innovative technology in biothreat detection

In this interview, we spoke to Warren Mino at Smiths Detection, about their innovative technology and its involvement within biothreat detection.

From Smiths Detection 15 Nov 2021

New WHO report highlights the alarming state of global access to insulin and diabetes care

A new report published by WHO in the lead-up to World Diabetes Day highlights the alarming state of global access to insulin and diabetes care, and finds that high prices, low availability of human insulin, few producers dominating the insulin market and weak health systems are the main barriers to universal access.

15 Nov 2021

Study: Patients meeting a particular criteria need invasive procedures to treat chronic neck pain

The use of radiofrequency ablation--targeted heat from an electrical current to ease nerve pain--may be helpful for treating chronic neck pain, but only in patients meeting particular criteria, conclude evidence-based consensus guidelines, published online in the journal Regional Anesthesia & Pain Medicine.

12 Nov 2021

Rare disease diagnosis by 100,000 genomes pilot

A team of researchers conducted a pilot study that enrolled families and undertook detailed clinical phenotyping of the proband to evaluate the effect of the whole genome sequencing approach on a genetic diagnosis of rare conditions by the NHS in the UK.

12 Nov 2021

EKF Diagnostics acquires ADL Health molecular diagnostic testing laboratory

EKF Diagnostics, the global in vitro diagnostics company, announces that it has acquired Advanced Diagnostic Laboratory LLC, a Texas based PCR-focused testing laboratory certified under the Clinical Laboratory Improvement Amendments for high-complexity molecular diagnostics testing.

From EKF Diagnostics 12 Nov 2021

Study may pave the way for a more personalized approach to COVID-19 diagnosis and treatment

Using some of the most advanced molecular sequencing tools available to evaluate COVID-19 rapid autopsy tissues, researchers have identified four major regulatory pathways, specific molecular effectors behind COVID-19 symptoms, and differences that drive diverging clinical courses among individual patients.

11 Nov 2021

RT-LAMP coupled solid-state nanopores for SARS-CoV-2 detection

Researchers discuss a highly sensitive, specific, and rapid SARS-CoV-2 detection platform by coupling the RT-LAMP with glass nanopore sensors.

11 Nov 2021

Protein in the blood could predict type 2 diabetes many years before diagnosis

A large study led by Lund University in Sweden has identified a protein in the blood that could predict type 2 diabetes up to nineteen years before the onset of the disease.

11 Nov 2021

UK Government opens large COVID testing facility in Edinburgh

The center, located at 2 Gilmore Park (EH3 9FN), is part of the largest network of diagnostic testing facilities created in British history.

11 Nov 2021

Appendicitis can be diagnosed using low-does CT scans

A new paper in the British Journal of Surgery, published by Oxford University Press, indicates it's now possible to diagnose appendicitis using low-does CT scans, decreasing the radiation exposure, which is of significant clinical importance especially in young patients.

11 Nov 2021

Phage-like particle system provides a platform for quick and easy vaccine generation

In this study, researchers report on the development of a monovalent lambda PLP-based vaccine against SARS-CoV-2 or MERS-Cov through decoration with the spike RBD proteins from either virus.

11 Nov 2021

Evidence that mild and even asymptomatic SARS-CoV-2 infection can lead to sustained immune activation

A paper published in the open-access journal Viruses, reports on a study investigating long-term changes to soluble inflammatory factors and cellular immune phenotype and function in 22 survivors of mild SARS-CoV-2 infection. The observations were then compared to 11 individuals who had recovered from other mild respiratory infections.

10 Nov 2021

Whole senome sequencing can effectively secure a diagnosis for people with rare diseases

A world-first scientific study, published today in the New England Journal of Medicine, has shown that whole genome sequencing can uncover new diagnoses for people across the broadest range of rare diseases investigated to date and could deliver enormous benefits across the NHS.

10 Nov 2021

New biomarkers could help determine synaptic damage and neurodegeneration in Alzheimer's

Alzheimer's disease is the main neurodegenerative disease in old people for which there is no treatment or efficient prevention yet.

10 Nov 2021

Diagnostic News and Research

Olympus announces first results of its AI-based pathology diagnostic tool for gastric cancer

New imaging software can accurately diagnose jaundice in the blink of an eye

Urinary SARS-CoV-2 RNA is a prognosticator of COVID-19

New AI application reads eye movements

Diagnostic sensitivity, viral load and infectivity of SARS-CoV-2 in paired respiratory and oral samples

Rapid thermal cycling approach for the detection of SARS-CoV-2

Smiths Detection: Innovative technology in biothreat detection

New WHO report highlights the alarming state of global access to insulin and diabetes care

Study: Patients meeting a particular criteria need invasive procedures to treat chronic neck pain

Rare disease diagnosis by 100,000 genomes pilot

EKF Diagnostics acquires ADL Health molecular diagnostic testing laboratory

Study may pave the way for a more personalized approach to COVID-19 diagnosis and treatment

RT-LAMP coupled solid-state nanopores for SARS-CoV-2 detection

Protein in the blood could predict type 2 diabetes many years before diagnosis

UK Government opens large COVID testing facility in Edinburgh

Appendicitis can be diagnosed using low-does CT scans

Phage-like particle system provides a platform for quick and easy vaccine generation

Evidence that mild and even asymptomatic SARS-CoV-2 infection can lead to sustained immune activation

Whole senome sequencing can effectively secure a diagnosis for people with rare diseases

New biomarkers could help determine synaptic damage and neurodegeneration in Alzheimer's

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News